CICLOSPORIN Oral

Clinical Indication

Dermatological disease

Comments

Full SCA

Date of classification

June 2014

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.